Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Dose escalation to dominant intraprostatic lesions with MRI-transrectal ultrasound fusion High-Dose-Rate prostate brachytherapy. Prospective phase II trial.
Gomez-Iturriaga A, Casquero F, Urresola A, Ezquerro A, Lopez JI, Espinosa JM, Minguez P, Llarena R, Irasarri A, Bilbao P, Crook J. Gomez-Iturriaga A, et al. Among authors: llarena r. Radiother Oncol. 2016 Apr;119(1):91-6. doi: 10.1016/j.radonc.2016.02.004. Epub 2016 Feb 15. Radiother Oncol. 2016. PMID: 26900090 Clinical Trial.
Safety of nivolumab in metastatic renal cell carcinoma patients: A real-life experience in a Spanish urology setting.
Amores Bermúdez J, Osman García I, Unda Urzáiz M, Jiménez Marrero P, Ledo Cepero MJ, Llarena R, Flores Martín J, Abad Vivas-Pérez JI, Rodrigo Aliaga M, Juarez Soto A. Amores Bermúdez J, et al. Among authors: llarena r. Actas Urol Esp (Engl Ed). 2019 Sep;43(7):364-370. doi: 10.1016/j.acuro.2019.03.005. Epub 2019 May 13. Actas Urol Esp (Engl Ed). 2019. PMID: 31097211 English, Spanish.
Outcomes after a first and/or second salvage treatment in patients with oligometastatic prostate cancer recurrence detected by (18-F) choline PET-CT.
Gomez-Iturriaga A, Casquero Ocio F, Ost P, Fernandez I, Rodeño E, Llarena R, Garcia-Olaverri J, Ortiz de Zarate R, Cacicedo J, Ahtamon A, Bilbao P. Gomez-Iturriaga A, et al. Among authors: llarena r. Eur J Cancer Care (Engl). 2019 Sep;28(5):e13093. doi: 10.1111/ecc.13093. Epub 2019 May 21. Eur J Cancer Care (Engl). 2019. PMID: 31115124
Outcomes of systemic targeted therapy in recurrent renal cell carcinoma treated with adjuvant sunitinib.
de Velasco G, Ruiz-Granados Á, Reig O, Massari F, Climent Duran MA, Verzoni E, Graham J, Llarena R, De Tursi M, Donskov F, Iglesias C, Pandha HS, Garcia Del Muro X, Procopio G, Oudard S, Castellano D, Albiges L. de Velasco G, et al. Among authors: llarena r. BJU Int. 2021 Aug;128(2):254-261. doi: 10.1111/bju.15356. Epub 2021 Apr 19. BJU Int. 2021. PMID: 33547860
28 results